BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 24528057)

  • 21. Diagnostic value of soluble B7-H4 and carcinoembryonic antigen in distinguishing malignant from benign pleural effusion.
    Jing X; Wei F; Li J; Dai L; Wang X; Jia L; Wang H; An L; Yang Y; Zhang G; Cheng Z
    Clin Respir J; 2018 Mar; 12(3):986-990. PubMed ID: 28127951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy.
    Bozkurt M; Yumru AE; Aral I
    Eur J Gynaecol Oncol; 2013; 34(6):540-4. PubMed ID: 24601047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pleural fluid carcinoembryonic antigen as a biomarker for the discrimination of tumor-related pleural effusion.
    Li H; Huang L; Tang H; Zhong N; He J
    Clin Respir J; 2017 Nov; 11(6):881-886. PubMed ID: 26662658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.
    Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting malignant and tuberculous pleural effusions through demographics and pleural fluid analysis of patients.
    Valdés L; San-José E; Ferreiro L; Golpe A; González-Barcala FJ; Toubes ME; Rodríguez-Álvarez MX; Álvarez-Dobaño JM; Rodríguez-Núñez N; Rábade C; Gude F
    Clin Respir J; 2015 Apr; 9(2):203-13. PubMed ID: 25849297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Auxiliary diagnostic value of tumor biomarkers in pleural fluid for lung cancer-associated malignant pleural effusion.
    Zhang H; Li C; Hu F; Zhang X; Shen Y; Chen Y; Li F
    Respir Res; 2020 Oct; 21(1):284. PubMed ID: 33121490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic performance of CTLA-4, carcinoembryonic antigen and CYFRA 21-1 for malignant pleural effusion.
    Chen M; Xie S; Wan C; Zeng N; Wu Y; Qin J; Shen Y; Wen F
    Postgrad Med; 2017 Aug; 129(6):644-648. PubMed ID: 28506100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions.
    Alataş F; Alataş O; Metintaş M; Colak O; Harmanci E; Demir S
    Lung Cancer; 2001 Jan; 31(1):9-16. PubMed ID: 11162861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The diagnostic value of apolipoprotein E in malignant pleural effusion associated with non-small cell lung cancer.
    Wang Y; Chen Z; Chen J; Pan J; Zhang W; Pan Q; Ding H; Lin X; Wen X; Li Y; Meng QH
    Clin Chim Acta; 2013 Jun; 421():230-5. PubMed ID: 23523589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superiority and clinical significance of Lunx mRNA in the diagnosis of malignant pleural effusion caused by pulmonary carcinoma.
    Tang Y; Xu L
    J Exp Clin Cancer Res; 2013 Jun; 32(1):37. PubMed ID: 23759037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions.
    Gaspar MJ; De Miguel J; García Díaz JD; Díez M
    Anticancer Res; 2008; 28(5B):2947-52. PubMed ID: 19031938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion.
    Han HS; Yun J; Lim SN; Han JH; Lee KH; Kim ST; Kang MH; Son SM; Lee YM; Choi SY; Yun SJ; Kim WJ; Lee OJ
    Int J Cancer; 2013 Aug; 133(3):645-52. PubMed ID: 23354517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions.
    Ferrer J; Villarino MA; Encabo G; Felip E; Bermejo B; Vilà S; Orriols R
    Cancer; 1999 Oct; 86(8):1488-95. PubMed ID: 10526277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying Thoracic Malignancies Through Pleural Fluid Biomarkers: A Predictive Multivariate Model.
    Porcel JM; Esquerda A; Martínez-Alonso M; Bielsa S; Salud A
    Medicine (Baltimore); 2016 Mar; 95(10):e3044. PubMed ID: 26962828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic accuracy of endostatin for malignant pleural effusion: A clinical study and meta-analysis.
    Tian P; Shen Y; Feng M; Zhu J; Song H; Wan C; Chen L; Wen F
    Postgrad Med; 2015 Jun; 127(5):529-34. PubMed ID: 25979108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic value of interleukin 21 and carcinoembryonic antigen levels in malignant pleural effusions.
    Bunjhoo H; Wang ZY; Chen HL; Cheng S; Xiong WN; Xu YJ; Cao Y
    Asian Pac J Cancer Prev; 2012; 13(7):3495-9. PubMed ID: 22994784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic Value of Six Tumor Markers for Malignant Pleural Effusion in 1,230 Patients: A Single-Center Retrospective Study.
    Fan X; Liu Y; Liang Z; Wang S; Yang J; Wu A
    Pathol Oncol Res; 2022; 28():1610280. PubMed ID: 35515016
    [No Abstract]   [Full Text] [Related]  

  • 38. Limited additive value of pleural fluid carcinoembryonic antigen level in malignant pleural effusion.
    Riantawan P; Sangsayan P; Bangpattanasiri K; Rojanaraweewong P
    Respiration; 2000; 67(1):24-9. PubMed ID: 10705258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pleural CEA, CA-15-3, CYFRA 21-1, CA-19-9, CA-125 discriminating malignant from benign pleural effusions: Diagnostic cancer biomarkers.
    Fazli Khalaf F; Asadi Gharabaghi M; Balibegloo M; Davari H; Afshar S; Jahanbin B
    Int J Biol Markers; 2023 Jun; 38(2):81-88. PubMed ID: 36942429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical value of jointly detection pleural fluid Midkine, pleural fluid adenosine deaminase, and pleural fluid carbohydrate antigen 125 in the identification of nonsmall cell lung cancer-associated malignant pleural effusion.
    Zhang F; Wang J; Zheng X; Hu L; Chen J; Jiang F; Wang Y
    J Clin Lab Anal; 2018 Oct; 32(8):e22576. PubMed ID: 29797475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.